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Background: Hypertriglyceridemia (HTG) is defined as a triglyceride (TG) plasma level exceeding 150 mg/dl and is
tightly associated with atherosclerosis, metabolic syndrome, obesity, diabetes and acute pancreatitis. The present study
was undertaken to investigate the mitochondrial, sub-mitochondrial and cellular proteomic impact of hypertriglyceridemia
in the hepatocytes of hypertriglyceridemic transgenic mice (overexpressing the human apolipoproteinC-III).
Methods: Quantitative proteomics (2D-DIGE) analysis was carried out on both “low-expressor” (LE) and “high-expressor”
(HE) mice, respectively exhibiting moderate and severe HTG, to characterize the effect of the TG plasma level on the
proteomic response.
Results: The mitoproteome analysis has revealed a large-scale phenomenon in transgenic mice, i.e. a general
down-regulation of matricial proteins and up-regulation of inner membrane proteins. These data also demonstrate that
the magnitude of proteomic changes strongly depends on the TG plasma level. Our different analyses indicate that, in HE
mice, the capacity of several metabolic pathways is altered to promote the availability of acetyl-CoA, glycerol-3-phosphate,
ATP and NADPH for TG de novo biosynthesis. The up-regulation of several cytosolic ROS detoxifying enzymes has also
been observed, suggesting that the cytoplasm of HTG mice is subjected to oxidative stress. Moreover, our results suggest
that iron over-accumulation takes place in the cytosol of HE mice hepatocytes and may contribute to enhance oxidative
stress and to promote cellular proliferation.
Conclusions: These results indicate that the metabolic response to HTG in human apolipoprotein C-III overexpressing
mice may support a high TG production rate and that the cytosol of hepatocytes is subjected to an important oxidative
stress, probably as a result of FFA over-accumulation, iron overload and enhanced activity of some ROS-producing
catabolic enzymes.Introduction
Hypertriglyceridemia (HTG) is defined as a plasmatic
triglyceride (TG) concentration exceeding 150 mg/dl.
It occurs either as a consequence of genetic disorders
(primary HTG) or as a feature of other metabolic diseases
such as obesity, metabolic syndrome and diabetes
(secondary HTG) [1]. It is also a risk factor for coronary
heart disease [1], nonalcoholic fatty liver disease [2] and
pancreatitis [3].* Correspondence: f.sluse@ulg.ac.be
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unless otherwise stated.Apolipoprotein C-III (ApoC-III) is a glycoprotein
component of TG-rich lipoproteins (mainly very-low
density lipoproteins, VLDLs) which is involved in the
control of TG metabolism in human [4] and mouse [5].
ApoC-III and TG plasmatic concentrations correlate [6] so
that disruption of ApoC-III gene results in hypotriglyceride-
mia [5]. In vivo and in vitro studies have established that the
control of ApoC-III on TG metabolism is achieved through
at least two mechanisms: (i) inhibition of lipoprotein lipase
(LPL) activity [7,8] and (ii) inhibition of hepatic uptake of
TG-rich remnants (TRLs) [9,10].
In 1990, Ito et al. published a study in which they
describe a transgenic mouse expressing the human
ApoC-III in hepatocytes and, to a lower extend, in intestinal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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proportional to the number of human ApoC-III gene copies
integrated in the genome. This feature allows distinguishing
“low-expressor” (mild HTG) and “high-expressor” (severe
HTG) HuApoC-III mice. Both categories are characterized
by larger and more numerous VLDLs, whereas only
high-expressor presents increased TG synthesis and
secretion rates by hepatocytes [12]. HuApoC-III mice
exhibit normal glucose homeostasis [13], body weight
[14], adiposity [15], pancreatic insulin secretion and
peripheral insulin sensitivity [16]. Therefore this mouse
model is a particularly desirable model to study HTG
without any potential interactive factors such as insulin
resistance or obesity [17].
So far, HuApoC-III mouse has been principally studied
through functional assays. At the hepatocyte level,
bioenergetic studies showed that mitochondria isolated
from HuApoC-III mouse present increased resting (state
IV) and normal phosphorylating (state III) respiratory
rates [18]. The higher state IV has been attributed to a
higher activity of the mitochondrial ATP-sensitive K+
channel (mitoKATP), resulting in a futile K
+ cycling
across the inner mitochondrial membrane and to a
mild uncoupling which does not affect phosphorylation
yield in state III [14,19]. Interestingly, it was also shown
that HuApoC-III mouse hepatocytes are subjected to a
remarkable oxidative stress, which has been attributed to
an intracellular lipid accumulation and a higher free fatty
acid (FFA) catabolism [20]. It has been hypothesized that
mitoKATP uncoupling activity is a mechanism contributing
to limit this stress in mitochondria [17]. At the organismic
level, other functional studies revealed that HuApoC-III
mouse presents higher liver oxygen consumption and
body metabolic rate. This may explain its normal body
weight despite a higher food intake [14].
Currently, the metabolic changes occurring in HuApoC-
III hepatocytes remain poorly understood. In order to
study global molecular adaptations set up in response to
an environmental (nutriment composition, pathology, etc.)
or an endogenous disruption (gene inactivation or over-
expression, transgene expression, etc.), comparative prote-
omics has been proven to be a powerful tool [21]. In 2005,
our group published a study [22] in which the proteomic
changes occurring in the ob/ob mouse model hepato-
cyte mitochondria were studied using the 2D-DIGE
(two dimensional-differential in-gel electrophoresis)
technology [23]. In this mouse, an inactivated form of
leptin is produced, resulting in obesity, hepatic steatosis
and numerous other disorders. This study allowed us to
characterize and understand the proteomic response
occurring in ob/ob mouse hepatocytes and to provide
new insights about steatosis.
In the present work, we used 2D-DIGE to characterize
the mitochondrial proteomic response of HuApoC-IIImouse hepatocytes to hypertriglyceridemia. This study was
performed on both low-expressor (LE) and high-expressor
(HE) HuApoC-III mice in order to assess a possible dose
response effect of TG plasmatic concentration on
mitochondrial proteomic adaptations. We also performed a
2D-DIGE analysis of the whole hepatocyte proteome in
order to integrate the results obtained at the mitochondrial
level in the cellular context. These different analyses
enabled to draw a global overview of the liver metabolic
response to hypertriglyceridemia and to propose literature-
based hypotheses attempting to rationalize our proteomic
observations.
Results
2D-DIGE comparative analysis of the whole mitochondrial
proteome
Using 2D-DIGE [21,23], the mitoproteomes of control
(WT, TG = 40 to 80 mg/dl), low-expressor (LE, TG = 200
to 400 mg/dl) and high-expressor (HE, TG = 800 to
1000 mg/dl) mouse hepatocytes have been compared in
order to characterize the dependence of the mitochondrial
metabolism upon the TG plasmatic concentrations.
A total of 1721 protein spots were detected in 2D-gels
(Additional file 1: Figure S1 and Additional file 2).
Among them 757 exhibited a statistically significant
expression variation (ANOVA-1 and t-test ≤ 0.05) between
WT and LE mice or WT and HE mice and were pointed
out as “protein spots of interest” (PSOI). Among them,
554 PSOI could be identified by mass spectrometry and
were classified according to their localization: 431 (77.8%)
corresponded to mitochondrial proteins (Additional file 1:
Figure S2A), out of which the major part (97.6%) were
matrix- (56.1%) or inner membrane- (41.5%) localized
(Additional file 1: Figure S2B).
A total of 391 PSOI presented a statistically significant
expression variation between WT and LE mice versus
716 between WT and HE mice. Out of these spots,
310 and 528 could be identified, respectively. Since
matricial and inner membrane PSOI were the two
major mitochondrial protein spot sub-populations of
our analysis (Additional file 1: Figure S2B), we aimed
to study the distribution of their expression variations
for each proteomic comparison (LE or HE mice versus
WT) (Figure 1). In Figure 1A, matricial and inner
membrane PSOI have been classified according to the
direction of their expression variation. Surprisingly,
we noticed that most of the matricial and inner membrane
PSOI are respectively down- (LE mice: 93.1%, HE mice:
97.5%) and up- (LE mice: 94.0%, HE mice: 89.0%)
regulated in hypertriglyceridemic mice compared to WT.
Figure 1B presents the average magnitude of matricial and
inner membrane PSOI expression variations, showing that
the amplitude of down- (matrix) or up- (inner membrane)
regulations are more important in HE mice (matrix: 0.57,
Figure 1 Matricial and inner membrane PSOI expression variations in LE and HE mice compared to WT. Panel A presents the number of
down- (white) and up- (black) regulated PSOI. Panel B shows the average magnitude of PSOI expression variations. Matricial and inner membrane
proteins were sorted out on the basis of localization data reported in UniProtKB/Swiss-Prot and KEGG Pathway. MAT, matrix; IM, inner membrane.
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0.85, inner membrane: 1.21).
Altogether, these results demonstrate that not only
the number, but also the magnitude of mitochondrial
proteomic changes strongly depends on the plasmatic
TG concentration. Moreover, the general down- and
up- regulation of the two major mitochondrial protein
spot sub-populations (respectively matrix and inner
membrane) (Figure 1A) tends to indicate that a large-scale
phenomenon happens in hypertriglyceridemic mouse
mitochondria. The relative proportion of matricial and
inner membrane proteins is probably modified, leading to
an increase of the (inner membrane)/(matricial) protein
amount ratio. Since this phenomenon dramatically alters
mitochondrial proteomic results by leading to an apparent
down-regulation of matrix proteins and up-regulation of
inner membrane proteins, it has the effect of preventing
direct quantitation of individual protein spots expression
variations inside each sub-mitochondrial compartment
(e.g. an enzyme with unaltered abundance within the
matrix proteome will appear down-regulated in mitochon-
drial comparison). In order to detect the potential adapta-
tions of the mitochondrial pathways, both matrix and
inner membrane proteomes had to be analyzed separately,
as detailed in the next sections.
Comparative analyses of sub-mitochondrial proteomes
Re-normalization of mitochondrial expression variations
Since the 2D-DIGE analyses of matrix and inner
membrane proteomes required performing 4 comparisons
between experimentally isolated proteomes (MATWT vs
MATLE, IMWT vs IMLE, MATWT vs MATHE and IMWT vs
IMHE), we first estimated the biological variation that
would be observed in each of these comparisons. Thisestimation is based on the re-normalization of the
results from the whole mitoproteome 2D-DIGE analysis
(see Additional files 3 and 4 for detailed procedure
description). In brief, we constructed the localization
specific distribution charts (matrix and inner membrane)
of PSOI logarithmic expression variations in each analysis
(LE and HE mice). Then we re-centered these distributions
on the abscissa axis origin by subtracting the average value
of the distribution to the initial values (Figure 2). The resul-
ting new logarithmic values were finally reconverted into
non-logarithmic ones, corresponding to the re-normalized
expression variations. In Figure 3, for LE and HE mice, the
matricial and inner membrane re-normalized expression
variations were classified according to their direction,
showing that a similar proportion of PSOI (about 50/50)
is down- and up- regulated in each case. Hence re-
normalization makes it possible to estimate quantitative
expression variations of protein spots inside each sub-
mitochondrial compartment (matrix and inner membrane).
The re-normalized expression variations were considered
as biologically relevant from +/-20% (≤ 0.83 or ≥ 1.2).
Figure 4 presents the proportion of PSOI exhibiting a
biologically relevant re-normalized expression variation.
This figure indicates that the proteomic response is much
more important in the HE mouse matricial proteome
(60.4%) when it is compared to the three others (LE matrix:
4.4%, LE inner membrane: 4.5%, HE inner membrane:
13.6%). This observation is related to the wider variance of
the normal distribution which characterizes the HE
mouse matricial proteome (Additional file 1: Table S1
and Figure 2). This finding is particularly relevant if the
number of PSOI exhibiting a biologically significant
re-normalized expression variation is reported to the total
number of protein spots (1721) which were initially detected
Figure 2 Distribution charts of PSOI logarithmic expression variations obtained after excluding outliers (Additional files 3 and 4). In
red, the normal adjustment curve and a straight line indicating the average of the distribution (μ). Panel A, before re-normalization; Panel B, after
re-normalization. MAT, matrix; IM, inner membrane.
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HE mouse matricial proteome (8.3%) and very low in the
three others (LE matrix: 0.3%, LE inner membrane: 0.3%,
HE inner membrane: 1.2%). Altogether, these results
strongly suggest that a marked proteomic adaptation occurs
within the mitochondrial matrix whereas the inner mem-
brane proteome remains quite unchanged in case of severe
hypertriglyceridemia. In case of moderate HTG, it seems
that neither matrix nor inner membrane are subjectedto a significant proteomic adaptation. A list of the PSOI
included in the re-normalization processes is presented
in Additional file 5 and summarizes the information
developed in the present section.
Experimental 2D-DIGE analyses of sub-mitochondrial
proteomes
Since the re-normalization of mitoproteome results
predicted only a weak proteomic response in LE mice,
Figure 3 Histogram classifying PSOI according to the direction
of their re-normalized expression variation. White, down-regulation;
Black, up-regulation; Grey, absence of regulation. MAT, matrix; IM,
inner membrane.
Figure 4 Histogram illustrating the proportion of PSOI
exhibiting a biologically relevant re-normalized expression
variation (+/- 20%: ≤ 0.83 or ≥ 1.2). Black, spots with a relevant
expression variation; White, spots without a relevant expression
variation. MAT, matrix; IM, inner membrane.
Ehx et al. Lipids in Health and Disease 2014, 13:116 Page 5 of 16
http://www.lipidworld.com/content/13/1/1162D-DIGE sub-mitochondrial comparisons on experimen-
tally isolated proteomes were only carried out between
WTand HE mice.
Matricial proteome 2D-DIGE has been performed on
experimentally isolated matrix proteome (see Materials and
methods section). A total of 1307 protein spots were
detected in 2D-gels (Additional file 1: Figure S3). Among
them, 195 (14.9%) presented a statistically significant
(t-test ≤ 0.01) and biologically relevant (+/- 20%: ≤ 0.83
or ≥ 1.2) expression variation, out of which 181 could be
identified by mass spectrometry (Additional file 6).
Among the identified spots, 173 (95.6%) correspond to
matricial proteins.
Inner membrane proteome A 2D-DIGE analysis was also
carried out on the experimentally isolated inner membrane
(see Materials and methods section for procedure description)
proteome to confirm the absence of major metabolic adapta-
tions in HE mice, as suggested by the re-normalization
procedure. A total of 1433 protein spots were detected in 2D-
gels (Additional file 1: Figure S4), out of which only 2 (0.1%)
presented a statistically significant (t-test ≤ 0.01) andbiologically relevant (+/- 20%: ≤ 0.83 or≥ 1.2) expression
variation. One of them could be identified as a very
long-chain specific acyl-CoA dehydrogenase of the
mitochondrial inner membrane (Additional file 7).
Quantitative comparison of experimental results and
re-normalization estimations
In order to demonstrate the accuracy of the re-
normalization method, we intended to compare the
experimental results and the estimations obtained by the
re-normalization for the matricial proteome of HE mice.
For this purpose, we only focused on the protein
spots exhibiting a statistically significant and biologically
relevant expression variation. We used DeCyder 7.0 to
match these spots between the mitochondrial and
matricial 2D-gels, allowing establishing a “spot-to-spot”
correspondence on the basis of 2D-gel patterns. The spots
that could be matched with a high degree of confidence
and identified as the same protein in both cases (only 39
spots) were selected. Their expression variations were
converted into logarithmic values and reported in a scatter
plot (Figure 5). This plot clearly shows that the expression
Figure 5 Scatter plot comparing the expression variations obtained by re-normalization and experimental approaches. Comparison has
been performed for HE mouse matricial proteome (x axis: experimental approach; y axis, re-normalized values). Dotted lines indicate the biological
significance cutoffs.
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demonstrating the similitude between the experimental
results and the re-normalized values. In addition the
very weak proteomic alteration within the inner membrane,
highlighted by the 2D-DIGE comparison on experimentally
isolated inner membrane proteomes (1 protein spots),
further supports the accuracy of the re-normalization
method, which predicted only weak protein expression
variation in this compartment (only 0.3% and 1.2% of
protein expression variation for LE and HE comparisons
respectively).
Cellular analysis
In order to integrate the results obtained at the mitochon-
drial level in a global cellular context, we performed a
2D-DIGE analysis on the whole hepatocyte proteome.
The comparison was only carried out between WT and HE
mice because of the strong dependence of the proteomic
response upon TG plasmatic concentration revealed by our
mitochondrial analyses. A total of 2736 protein spots were
detected in 2D-gels (Additional file 1: Figure S5).
Among them, 153 (5.6%) presented a statistically significant
(t-test ≤ 0.05) and biologically relevant (+/- 20%: ≤ 0.83
or ≥ 1.2) expression variation, among which 76 could be
identified by mass spectrometry (Additional file 8). In
opposition to the mitochondrial analysis in which 73% ofdifferentially expressed protein spots could be identified
by mass spectrometry, only 50% were identified in the
cellular analysis. This observation probably results from
the higher complexity of the cellular proteome (2736
detected protein spots vs 1721 in the mitochondrial
proteome), therefore inducing slight overlaps of several
spots and hampering the proper identification of differen-
tially expressed spots.
Description of HE mouse metabolic adaptations
Due to the large amount of available data and (sometimes)
the high number of spots identified as the same protein
(because of post-translational modifications mainly
affecting the isoelectric point), only proteins presenting
completely up- or down-regulated “spot trains” were
considered as biologically up- or down-regulated.
Mitochondrial matrix
Several enzymes of glycine and cysteine catabolism are
up-regulated in HE mice, indicating that the capacity of
these pyruvate-generating pathways is increased, whereas
the strong down-regulation of pyruvate carboxylase (which
converts pyruvate into oxaloacetate as initial step of gluco-
neogenesis) suggests that gluconeogenesis presents a
decreased capacity. These proteomic changes are probably
accountable for more important substrate availability for
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tion of acetyl-CoA from pyruvate. Accordingly, the PDH
enzymatic complex was shown to be up-regulated in
HE mice as well as numerous enzymes of β-oxidation
and leucine and isoleucine catabolism, indicating that
the capacity of these different acetyl-CoA-forming path-
ways may be increased. Conversely, the down-
regulation of one enzyme involved in mitochondrial FFA
biosynthesis and three proximal Krebs cycle enzymes
(aconitase, isocitrate dehydrogenase, α-ketoglutarate
dehydrogenase) suggest that the capacity of these acetyl-
CoA-consuming pathways is decreased in HE mice.
Altogether, such adaptations may be responsible for a
more important acetyl-CoA availability for other
metabolic routes.
Some enzymes of valine, proline, arginine and glutamate
catabolism were also shown to be up-regulated. Interest-
ingly, the capacity of numerous catabolic (β-oxidation,
amino acid degradation) and some anabolic (gluconeogen-
esis, mitochondrial FFA biosynthesis) pathways seems to
be respectively increased and decreased in HE mice. This
overall tendency towards catabolism may result in a
more important availability of reduced cofactors
(NADH, FADH2) notably as substrates of the respiratory
chain complexes, indirectly leading to a higher ATP
production rate. Notably, we found that the two subunits
of the electron-transferring flavoprotein (ETFA and ETFB),
which acts as an acceptor of electrons from FADH2, are
strongly up-regulated in HE mice. This protein complex is
re-oxidized by the ETF-ubiquinone oxidoreductase, which
transfers electrons from ETF to the ubiquinone pool of the
respiratory chain.
In addition to aconitase, isocitrate dehydrogenase
and α-ketoglutarate dehydrogenase down-regulation,
we noticed that three other Krebs cycle enzymes,
namely succinyl-CoA dehydrogenase, fumarase and malate
dehydrogenase, are strongly up-regulated in HE mice.
These proteomic changes suggest that the capacity of the
first part of Krebs cycle may be decreased in HE mice,
contributing to heighten the availability of acetyl-CoA
(as described above), whereas the capacity of the second
part of Krebs cycle may be increased. Anaplerosis probably
plays a key role in supporting this higher capacity since our
results indicate that numerous α-ketoglutarate- (arginine,
proline and glutamate catabolism) and succinyl-CoA-
(isoleucine and valine catabolism, β-oxidation) producing
pathways present an increased capacity in HE mice.
The up-regulation of fumarase and malate dehydrogenase
can be rationalized with regard to the up-regulation
of ornithine aminotransferase, an urea cycle enzyme, and
mitochondrial aspartate aminotransferase. These different
enzymes are involved in the “aspartate-argininosuccinate”
shunt, which includes both urea and Krebs cycle enzymes
and allows recycling of a product of urea cycle (fumarate)into a substrate (aspartate) in order to ensure a continuous
operation of the metabolic pathway. Fumarate released by
the urea cycle in the cytoplasm is imported to the
mitochondrion and is converted into aspartate by three
successive enzymatic reactions catalyzed by fumarase,
malate dehydrogenase and aspartate aminotransferase.
Aspartate is finally exported to the cytoplasm where it can
re-enter the urea cycle to form argininosuccinate. Our
results suggest that the urea cycle capacity is probably
increased in HE mice and that its higher capacity
may be supported by an up-regulation of the aspartate-
argininosuccinate shunt enzymes.
Whole hepatocyte
Only 23 spots corresponding to 12 different mitochondrial
proteins were shown to be differentially regulated within
the cellular proteome, this low number being attributable
to the “dilution” of mitochondrial proteins in terms of
diversity and concentration. This dilution effect may lead
to an inaccurate quantitation of protein abundance which
is inherent to 2D gel-based techniques. For instance,
the expression level of some mitochondrial proteins
observed at the cellular level correlated with the
mitoproteome analysis for 16 spots accounting for 4
different mitochondrial proteins (CPSM, OAT, ACON,
SARDH). However, 7 other spots accounting for 7
different mitochondrial proteins (ATPB, IMMT, OTC,
AATM, HMCS2, ETFB, SODM) showed an opposite
regulation depending on the proteome. These apparent
contradictions are unlikely to be of biological origin since
all concerned proteins were mostly identified as charge
variants (due to post-translational modifications as ex-
plained above) within the mitoproteome analysis, whereas
only one single spot was detected in the cellular proteome
as being differentially expressed. As a consequence, results
obtained for these mitochondrial proteins in the context of
the cellular proteome comparative analysis were not
considered as representative and were not used to
infer biological variations.
One glycolytic (α-enolase) and one pentose phosphate
pathway (transketolase) enzyme are up-regulated in HE
mice compared to WT, suggesting that the capacity of
these metabolic routes is increased. Pentose phosphate
pathway catabolizes glucose into fructose-6-phosphate and
glyceraldehyde-3-phosphate, which can enter glycolysis to
produce pyruvate. Consequently, glycolysis and pentose
phosphate pathway probably contribute to increase reduced
cofactor (NAD(P)H), ATP and pyruvate production rates in
HE mice.
Arginase, an urea cycle enzyme, is up-regulated in HE
mice whereas cytoplasmic aspartate aminotransferase,
which catalyzes the transamination of aspartate into
oxaloacetate, is down-regulated, indicating a higher
aspartate availability for the urea cycle. Together with
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aspartate-argininosuccinate shunt enzymes revealed by
our mitochondrial analyses, these proteomic changes
suggest that the urea cycle capacity may be increased
in HE mice. However, this feature remains in doubt
since we also noticed that argininosuccinate synthase,
another urea cycle enzyme, is down-regulated.
Several cytoplasmic enzymes involved in the defense
against oxidative stress, peroxiredoxin 1, glutathione-S-
transferases and carbonic anhydrase 3, are strongly
up-regulated in HE mice. In case of oxidative stress,
molecules (especially unsaturated lipids) are damaged
by reactive oxygen species (ROS), generating peroxide
chemical groups which prevent the correct achievement of
biological functions. Peroxidized molecules must be either
reduced or eliminated to allow a continuous operation of
cellular metabolism. Peroxiredoxin-1 is involved in the
reduction of such molecules [24], whereas glutathione-S-
transferases conjugate them with glutathione as a destruc-
tion target signal [25]. Regarding carbonic anhydrase 3,
previous studies suggested that it may act as an “electron
donor” to ROS, indirectly preventing other molecules from
oxidative damages, after which it may be targeted to
destruction by a specific S-glutathiolation [26].
Ferritin, a protein of iron metabolism, was shown to
be up-regulated in HE mice. This protein binds free
cytoplasmic Fe3+, preventing these highly reactive cations
from inducing undesirable chemical effects.
Two proteins involved in cell signaling, ERK2 and
NDRG2, are respectively up- and down- regulated in
HE mice. ERK2 belongs to the MAPK family and par-
ticipates to the transduction of cellular proliferation
signals. Little is known about NDRG2, but it may be
involved in the inhibition of cellular proliferation [27].
Altogether, these results suggest that the hepatocytes
of HuApoC-III transgenic mice may be subjected to
an induction of cellular proliferation.
Discussion
Hypertriglyceridemia is commonly associated with
diabetes, obesity and metabolic syndrome [1], in which
insulin resistance is also a major component of pathogen-
esis. Since lipid metabolism is under the tight control of
insulin action, the discrimination of the relative contribu-
tion of HTG and insulin resistance to the pathogenesis of
these disorders may be very difficult. Hypertriglyceridemic
mice overexpressing the human apolipoproteinC-III have
been proven to present no difference of plasma insulin
and glucose concentrations [13,16,28], adipocytes insulin
response [13], pancreatic insulin secretion [16] and plasma
glucose disappearance rates [16] in comparison to
WT littermates. Consequently these mice are currently
considered as the most adequate model to study the
impact of HTG independently of insulin resistance [17].In the present work, we aimed to characterize the
mitochondrial and cellular metabolic adaptations
related to HTG in the hepatocytes of the HuApoC-III
transgenic mouse by using 2D-DIGE. Since the hepatic
lipid physiology of HuApoC-III mice was shown to be
strongly dependent on the TG plasmatic concentration
[12], comparative proteomic analyses were carried out
on both moderately (LE) and severely (HE) hyper-
triglyceridemic mice. Changes in protein abundance
were considered as biologically relevant while exceed-
ing ±20%. Indeed it is well established that 2D-DIGE,
in which the use of an internal standard dramatically
reduces gel-to-gel experimental variability, enables to
detect changes in protein abundance lower than 10%
with a p-value inferior to 0.05 with only a small number
of replicates [22]. In such a context, ±20% differential
expression can be considered as an acceptable cutoff
to assess biological variations, as frequently assumed
in 2D-DIGE experiments (for example see [29,30]).
In the following sections, the authors will attempt to
propose literature-based hypotheses to rationalize their
proteomic observations. They insist on emphasizing that
these hypotheses must not be considered as firm assertions,
but rather aim to provide tracks for future more
specific investigations concerning the impact of HTG
on liver metabolism.
The general down- and up-regulation of matricial and
inner membrane proteins may be related to several
causes in HuApoC-III mouse mitochondria
Considering its primordial function in cellular metabolism,
we first aimed to study the impact of HTG on the mito-
chondrial proteome. Surprisingly, our analyses evidence
that matricial and inner membrane proteins are respectively
down- and up-regulated in HuApoC-III mice. To our
knowledge, such a large-scale phenomenon has never been
described in the context of a mitochondrial proteomic
analysis. Several possible causes to this phenomenon
may be considered in the light of the following previously
published findings. HuApoC-III hepatic mitochondria
were shown to exhibit a higher respiratory rate in non-
phosphorylating condition [18]. This observation has been
attributed to the higher activity of the mitochondrial
ATP-sensitive K+ channel (mitoKATP) in HuApoC-III
mice, which results in mild uncoupling of oxidative
phosphorylation (OXPHOS) [14]. As observed with other
OXPHOS uncoupling mechanisms (e.g. uncoupling
proteins, UCPs), the mitoKATP higher activity has been
proposed to lower the ROS production by accelera-
ting the electron transport through the respiratory
chain [31]. This has been confirmed in the mitochondria
of the HuApoC-III mouse in which lower rates of H2O2
production were observed, in a reversible manner by
mitoKATP antagonists [20]. Proteomic data from the
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mitochondrial oxidative stress since peroxide reductase
was down-regulated in HuApoC-III mice. On the other
hand, a cytoplasmic oxidative stress could be highlighted
in these mice as a result of higher activities of xanthine
and NADPH oxidases [20]. Therefore, HuApoC-III mito-
chondria were proposed to be protected from cytoplasmic
oxidative stress by the increased activity of mitoKATP chan-
nel [20]. It is worth noticing that abundance changes of
mitoKATP could not be assessed in the present analyses
because 2D-DIGE (such as the other gel-based proteomic
techniques) does not allow to resolve highly hydrophobic
proteins in 2D-gels due to protein aggregation phenomena
affecting first- and second-dimension electrophoreses.
Altogether, these findings indicate that the divergence
between MAT and MIM proteins may result from one
or several of the following causes. (1) Alteration of the
mitochondrial morphology: ultrastructural alterations
were found in the mitochondria of mice in which HTG
was induced by a high-fat diet [32]. These alterations
included an increased number of disarrayed cristae in
the inner membrane and a reduced electron density in
the matrix, which may possibly be rooted to a lower
protein content [30-32]. The authors suggested that
these alterations may be a consequence of HTG-induced
cellular oxidative stress. (2) Lipid peroxidation in the
mitochondrial membrane: enhanced cytoplasmic ROS
production and subsequent lipid peroxidation byproducts
may disrupt the fluidity and integrity of the mitochondrial
inner membrane, altering OXPHOS activity and leading
to mitochondrial dysfunction. In response to this stress, a
membrane biogenesis may be induced through retrograde
signaling [33] to compensate the dysfunction of inner
membrane proteins. (3) Alteration of mitochondrial
protein import: since the import of mitochondrial proteins
is partially regulated by cytoplasmic proteins [33], oxidative
stress may affect this process and thereby alter the
balance between matricial and inner membrane proteins.
(4) Alteration of matricial protein folding: our matricial
analysis highlighted the up-regulation of the stress-70
protein, which is known to be implicated in the folding of
mitochondrial proteins. Since the expression of this
protein is inducible through stress-sensitive retrograde
signaling [33], its up-regulation may either highlight a
defect in the folding of matricial proteins (resulting in
the proteolysis of misfold proteins) or further support
hypothesis 2. (5) Alteration of the mitochondrial biogenesis
signaling: mitochondrial biogenesis has been shown to be
directly regulated through cytoplasmic oxidative stress
response pathways such as the Nrf2 pathway [34], which
may also be implicated in mitoKATP activity regulation
[35]. A complex interaction between these pathways may
therefore induce a higher inner membrane biogenesis in
HuApoC-III mice.The extent of metabolic adaptations occurring in
HuApoC-III mouse hepatocytes strongly depends on the
TG plasmatic concentration
The 2D-DIGE analysis that we performed on the whole
mitoproteome demonstrated that the number and the
magnitude of mitochondrial proteomic changes are
higher in HE mice compared to LE mice. Furthermore
re-normalized and experimental results obtained for
sub-mitochondrial compartments revealed that a significant
adaptation of the matricial proteome occurs in HE mice
but not in LE mice; regarding the inner membrane
proteome, surprisingly, it was not significantly modified
whatsoever the TG level. These data suggest that the
extent of metabolic adaptations occurring in HuApoC-III
mouse hepatocytes strongly depends on the TG plas-
matic concentration. Accordingly, Aalto-Setälä et al.
demonstrated that numerous alterations of VLDL and
lipid hepatic physiology are more extensive in HE mice
compared to LE mice whereas some of them occur only in
HE mice [12]. For example, the TG production rate by
hepatocytes is twice higher in HE mice compared to
control but is not significantly modified in LE mice. Here
we demonstrate that the physiological alterations
occurring in HuApoC-III mice are probably related to
metabolic changes of which the magnitude strongly
increases with the hypertriglyceridemia level.
Re-normalizing protein expression variations can be used
as a first approach to counterbalance the effects of a
biological large-scale proteomic phenomenon
Global investigation tools such as transcriptomics and
proteomics have been developed to study the expression
level of genes and proteins in living organisms. Such global
approaches suffer from a high influence of experimental
artifacts on the quantification of expression levels.
Therefore normalization methods had to be designed to
correct systematic experimental bias and ensure correct
quantification. In 2D-DIGE, such normalization is per-
formed by the DIA (Differential In-gel Analysis) module of
the DeCyder software to counterbalance the different
fluorescence quantum yields of Cy3 and Cy5 as well as
many other artifacts occurring at the level of protein assay,
labeling, loading on the gel, etc [36]. In the present work,
the comparative analysis of the HuApoC-III mouse mito-
proteome revealed a general down- and up-regulation of
matricial and inner membrane proteins respectively
which hampered the characterization of the different
mitochondrial metabolic pathways adaptations to hypertri-
glyceridemia. As a first approach, we considered this large-
scale phenomenon as a biological bias and performed
a re-normalization (since the DIA module of DeCyder also
performs a normalization, we added the prefix “re-”) aim-
ing to predict the expression variations of proteins inside
the two sub-mitochondrial compartments independently
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related to the “central tendency normalization”, which is
commonly applied in label-free mass spectrometry and
transcriptomics and consists in re-centering peptide
abundance ratios and intensities of hybridized probes
(respectively) around a fixed constant (mean, median, etc.)
[37]. For the matricial proteome of HE mice, we could
compare the expression variations predicted by the
re-normalization to those resulting from an independent
2D-DIGE analysis (Figure 5). This comparison revealed a
high similarity between the expression variations obtained
by both approaches and confirmed the validity of the
re-normalization method.
In HE mice, the capacity of several metabolic pathways is
modified to increase the availability of acetyl-CoA, ATP,
glycerol-3-phosphate and NADPH for de novo TG
biosynthesis
The results of our proteomic analyses suggest that the
capacities of numerous catabolic (glycolysis, β-oxidation,
pentose phosphate pathway, amino acid degradation, pyru-
vate dehydrogenase) and some anabolic (gluconeogenesis,
mitochondrial FFA biosynthesis) pathways are respectively
increased and decreased in HE mice (Figure 6). The higher
capacity of β-oxidation highlighted here is in good
agreement with previous functional measurement show-
ing that liver mitochondria of HuApoC-III mice present aFigure 6 Main adaptations of the mitochondrial and cellular proteom
respectively indicate up-regulation or down-regulation as found in our pro
Stoichiometries of the reactions are not showed. TAG, Triglycerides; CI-III-IV, C
FFA, Free Fatty Acids, ETFDH, Electron-transferring-flavoprotein dehydrogenashigher state III respiration supported by palmitoylcarni-
tine which indicates an enhanced β-oxidation rate [20].
We also evidenced that the proximal part of the Krebs
cycle exhibits a decreased capacity in HE mice. Altogether
these different metabolic alterations may notably be
responsible for a higher availability of reduced cofactors
(notably NADPH from the pentose phosphate pathway),
ATP, acetyl-CoA and some other metabolites (notably
glycolytic side-produced metabolites such as glycerol-3-
phosphate). The increased availability of reduced cofactors
may generate a higher ATP production rate by the
respiratory chain contributing to the greater ATP
availability. Accordingly, the oxygen consumption rate
of liver fragments from HuApoC-III mouse has been
shown to be increased compared to control, indicating a
higher respiratory activity [14].
Interestingly, Aalto-Setälä et al. demonstrated that the
hepatic TG production rate is increased in HE mice
compared to control, but is not significantly modified
in LE mice [12]. In another study, the higher hepatic
TG production characterizing the hypertriglyceridemic
ldlr-/- mouse has been attributed to an increased de novo
lipogenesis [38]. Since the substrates of TG biosynthesis
are acetyl-CoA, glycerol-3-phosphate, ATP and NADPH,
we hypothesize that the metabolic adaptations of HE
mouse hepatocytes revealed by our proteomic analyses
may sustain an acute cytoplasmic TG biosynthesis, whiches in response to HTG in HE mice. Pathways in red and blue
teomic analyses. Dashed lines indicate an assumed capacity alteration.
omplexes I-III-IV; ATPs, ATP Synthase; UQ, Ubiquinone; UQH2, Ubiquinol;
e.
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characterizing the hepatocytes of HE mice. Since most
of the enzymes involved in TG biosynthesis are highly
hydrophobic, it is not surprising that 2D-DIGE, which is
particularly suitable for the analysis of soluble proteomes,
did not allow detecting their probable variation of expres-
sion in the present study.
In HE mice, the capacity of the urea cycle is enhanced to
support the higher capacity of amino acid catabolism
The results of our proteomic analyses indicate that
several enzymes belonging or associated to the urea
cycle are up-regulated in HE mice, suggesting that the
capacity of this metabolic pathway is increased (Figure 6).
The biological function of urea cycle consists in detoxifying
ammonium, mainly produced by amino acid catabolism, by
converting it into urea. Since our proteomic analyses
demonstrated that the capacity of numerous amino acid
catabolic pathways is increased in HE mice, enhanced
capacity of urea cycle may serve to prevent hepatocytes
from severe damages resulting from ammonium accumula-
tion. Accordingly, it has been shown that mice fed with a
high fat diet present an increased urea cycle capacity and
activity [39,40]. It has to be emphasized that we also
detected that argininosuccinate synthase, a key enzyme of
urea cycle, is down-regulated in HE mice so that the overall
increase of urea cycle capacity remains in doubt.
In HE mice, the induction of several anti-ROS systems
suggests that the cytosol of hepatocytes is subjected to
an important oxidative stress
The 2D-DIGE analysis carried out on the whole hepatocyte
proteome revealed that several enzymes involved in the
defense against oxidative stress, i.e. peroxiredoxin 1,
glutathione-S-transferases (Mu and P classes) and carbonic
anhydrase 3, are strongly up-regulated in HE mice. Since
anti-oxidant enzymes are substrate-inducible [41], their
up-regulation suggests that the cytosol of HuApoC-III
mice exhibits an important oxidative stress, implying lipid
peroxidation. In agreement with these findings, previous
studies demonstrated that HuApoC-III mice exhibit a
cytoplasmic oxidative stress originating from higher
activities of NADPH and xanthine oxidases whereas a
lower ROS production was observed at the mitochondrial
level [20]. Consequently, the cytoplasmic oxidative stress
was hypothesized to result from intracellular FFA accumu-
lation in hepatocytes. Indeed, such an accumulation
may lead to higher activities of peroxisomal and
microsomal fat oxidation pathways, which have been
shown to induce NADPH and xanthine oxidases and
also to be ROS-generating through the activities of
cytochromes P450 CYP4A and CYP2E1 [42,43]. As
discussed above, the cytoplasmic oxidative stress may
induce several ROS-sensitive pathways that may inturn affect mitochondrial functions. Specifically, the
ROS-inducible nuclear erythroid 2-related factor (Nrf2)
has been shown to be implicated in (1) mitochondrial
protection from oxidative stress in mice fed a high fat diet
[44], (2) mitochondria biogenesis regulation [34] and (3)
probable regulation of the mitoKATP channel activity [35].
Considering the large-scale mitochondrial adaptations
observed here and the evidence of cytoplasmic oxidative
stress, the induction of such a cytoplasmic ROS-sensitive
pathway seems to be the most reliable hypothesis to
explain our mitochondrial results.
In HE mice, iron over-accumulation may contribute to
enhance cytosolic oxidative stress
Recently, hepatic iron overload has attracted much
attention because excess iron accumulation causes
severe cellular dysfunction by facilitating production
of reactive oxygen species, mainly through the Fenton
reaction [45]. In this way, hepatic iron overload is newly
considered as a predisposing factor and a possible thera-
peutic target for metabolic syndrome and non-alcoholic
steatohepatitis, where hepatic oxidative stress is frequently
observed [46]. Interestingly our study evidenced the
upregulation of ferritin, involved in free iron storage,
in HTG mice liver. As the translation of this protein
is known to be enhanced by increased iron levels in
hepatocyte cytosol, we can hypothesize that HTG mice
undergo a hepatic iron overload [47,48]. Moreover, our
proteomic analyses also revealed that urea cycle capacity,
as well as hepatocyte proliferation (through up-regulation
of ERK2 and down-regulation of NDRG2), are probably
enhanced in HE mice. In good agreement with these
findings, hepatic iron overload has been shown to induce
increased urea cycle capacity and hepatocyte proliferation
in mice [49]. Altogether, these results suggest that HTG
can be seen as a causative factor for hepatic iron overload,
which may participate to the general oxidative stress.
HuApoC-III mice are more prone to develop non-alcoholic
steatohepatitis despite absence of steatosis and insulin
resistance
Non-alcoholic fatty liver disease (NAFLD), defined as an
alcohol-independent deposit of fat in the liver, includes
non-alcoholic steatohepatitis (NASH). NASH is a severe
NAFLD form in which fat accumulation is accompanied
by necroinflammatory activity, and is now recognized as
one of the most common causes of chronic liver disease
[50]. Interestingly, our results highlight that the liver of
HuApoC-III mice presents a marked oxidative stress
probably due to an enhanced extra-mitochondrial FFA
oxidation. Oxidative stress is currently considered as a
trigger factor for the development of NASH [51]. The
present study suggest that neither steatosis (which is
another key factor of NASH and is absent in HuApoC-III
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ROS production are necessary for the induction of
FFA-mediated oxidative stress. This feature suggests
that higher triglyceride and plasma FFA concentrations are
sufficient to induce hepatic oxidative stress and therefore
increase the probability of NASH development. In
good agreement with this assumption, another study
demonstrated that HuApoC-III mice fed a high fat
diet become insulin-resistant and develop steatosis and
NASH [28]. Our results also indicate that iron overaccumu-
lation may participate to the HTG-induced oxidative stress
and therefore be implicated in the pathogenesis of
NASH. Finally, alterations of the mitochondrial structure
(cristalline inclusions made of dysfunctional inner
membrane micelles) have been observed in patients
with NASH [52]. This may further support the hypothesis
of an alteration of the mitochondrial structure in
HuApoC-III mice.
Conclusion
In the present work, we characterized the mitochondrial,
sub-mitochondrial and cellular proteomic adaptations
related to hypertriglyceridemia in the hepatocytes of the
transgenic HuApoC-III mouse model. The mitochondrial
analysis demonstrated that the extent of the proteomic
response strongly depends on the TG plasma level and
revealed a large-scale phenomenon, i.e. a respective
general down- and up-regulation of matricial and inner
membrane proteins. Further analyses of sub-mitochondrial
and cellular proteomes indicate that the metabolic
adaptations occurring in HE mouse hepatocytes induce an
enhanced acetyl-CoA, glycerol-3-phosphate, ATP and
NADPH availability for de novo TG biosynthesis. They
also strongly suggest that the cytosol of HuApoC-III
mouse hepatocytes is subjected to an important oxidative
stress, probably as a result of FFA over-accumulation, iron




The human apolipoprotein C-III transgenic mice (line
3707), described elsewhere [14], were bred within the
Department of Physiology and Biophysics at the State
University of Campinas (Campinas, Brazil) and were
provided by Dr. H.C.F. Oliveira. Experiments were
approved by the ethics committee of the Universidade
Estadual de Campinas and by the Animal Ethical
Committee of the University of Liege (Belgium) in
accordance with the institutional guidelines for animal
care. Mice had access to standard laboratory rodent
chow (Nuvital CR1, Parana, Brazil) and water ad libitum
and were housed at 22 ± 2°C, on a 12 h light/dark cycle.
Only males heterozygous apolipoprotein C-III transgenic(HTG, n = 9 comprising LE +HE mice) and nontransgenic
(WT, n = 6) littermates, aged from 6 to 7 months,
were used in this study. Total plasmatic triglyceride
levels were determined by enzymatic-colorimetric method
according to the manufacturer’s instructions (Chod-Pap;
Roche Diagnostic GmbH, Mannheim, Germany). Mice
were divided into three groups according to fasting
plasma triglyceride levels: moderately hypertriglyceridemic
(LE: 200 mg/dl to 400 mg/dl), severely hypertriglyceridemic
(HE: 800 mg/dl to 1000 mg/dl) and control (WT: 40 mg/dl
to 80 mg/dl).
Isolation and purification of mitochondria
Isolations of mitochondria were independently performed
on 3 different mice for each TG level group (WT, LE, HE)
(total number of samples: 3×3 = 9). Mouse livers were
homogenized in 5 ml of sucrose medium (250 mM
Sucrose, 1 mM EGTA, 10 mM HEPES-KOH pH 7.4). Cell
debris was removed by centrifugation at 600 × g for
10 min at 4°C and mitochondria were finally sedimented
from the supernatant by centrifugation at 15 500 × g for
15 min at 4°C. The purification was conducted according
to Sickmann et al. [53]. Briefly, isolated mitochondria
were washed twice in isolation medium, loaded on top of
a three step sucrose gradient (3 ml 60%, 4 ml 32%, 3 ml
23%) and centrifuged at 120 000 × g for 1 h at 4°C. The
mitochondria were collected from the interface between
32% and 60% sucrose-steps, washed twice with stock solu-
tion (250 mM sucrose, 1 mM EDTA, 24 mM Tris-HCl
pH 7.4, supplemented with Complete EDTA free protease
inhibitor cocktail tablets (Roche Diagnostics)) and stored
at -80°C until use.
Submitochondrial compartment isolation
Isolations of sub-mitochondrial compartments were
independently performed using parts of the 3 purified
mitochondrial samples for each TG level group (WT, HE)
(total number of samples for each sub-mitochondrial
compartment: 3×2 = 6). Matrix was isolated according
to the method described by Sottocasa et al. [54].
Briefly mitochondria were subjected to combined
swelling-shrinking followed by sonication. The membrane
fraction was pelleted by centrifugation at 105.000 × g during
1 h. The resulting supernatant was finally filtered through
an Amicon Ultra-4 PLGC Centrifugal Filter Unit (EMD
Millipore) according to manufacturer instructions to raise
the protein concentration of the extracts to 5 mg/ml. For
mitochondrial inner membrane isolation, an amount of
mitochondria corresponding to 1 mg of protein was
suspended in 1.5 ml of 10 mM Tris-HCl buffer
pH 7.5. After 15 min of incubation at 4°C under agitation,
the mitoplasts were pelleted at 16 000 × g during 5 min at
4°C and resuspended in 1 ml of isotonic medium
(70 mM sucrose, 210 mM mannitol, 1 mM EDTA,
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at 4°C under agitation, mitoplasts were pelleted and
resuspended in 230 μl of extraction solution
(250 mM KCl, 0.035% Digitonin (w/v), 1 mM EDTA,
30 mM Tris-HCl pH 7.5) and incubated 15 min at 4°C
under agitation. Finally, inner mitochondrial membranes
were pelleted by Airfuge ultracentrifugation 10 min at
120 000 × g, resuspended in isotonic solution and
stored at -80°C until use. All solutions used for the
sub-mitochondrial compartment isolations were sup-
plemented with Complete EDTA free (Roche).
Sample preparation for comparative proteomic studies
Purified mitochondria, matrix and inner membrane
extracts were resuspended in a lysis buffer (7 M urea,
2 M thiourea, 2% ASB-14 (w/v), 10 mM DTT, 0.5 M
EDTA, Complete EDTA free (Roche), 50 mM Tris-HCl
pH 7.5) and intensively vortexed for 30 min at room
temperature. After solubilization, the proteins were
centrifuged at 10 000 × g to remove any insoluble
material. In order to remove excess of salt, fatty acids and
nucleic acids, protein extracts were cleaned by using the
2D-Clean Up kit (GE Healthcare).
Extractions of cellular proteomes were independently
performed on 3 different mice for each TG level group
(WT, HE) (total number of samples: 3×2 = 6). Total
cellular proteome was extracted from liver homogenized
in sucrose medium supplemented with Complete EDTA
free (Roche). In brief, homogenates were solubilized in a
1% SDS solution, were sonicated 30 sec on ice and
vortexed 5 min. Insoluble fraction was spun down by
centrifugation for 30 min at 50 000 × g. With respect to
the complexity of the cellular proteome and the higher
presence of contaminating molecules in the total liver
protein extracts (in comparison to the mitochondrial
extracts), a phenol extraction method has been performed
on these samples [55]. In brief, an equal volume of Tris,
pH 8.5, buffered phenol (stored at 4°C) was added to 2 mg
of protein extracts and vortexed 30 min at 4°C. An equal
volume of extraction buffer (10% glycerol (v/v), 2 mM
EDTA, 0.7 M sucrose and 50 mM Tris-HCl pH 7.5)
was added and the contents were centrifuged 10 min
at 15 000 × g. The top phenol phase was transferred
to a fresh tube, mixed with 5 volumes of ammonium
acetate in methanol (stored at -20°C) and incubated 30 min
at -20°C. The mixture were centrifuged at 15 000 × g for
10 min and the supernatants discarded. The pellets were
resuspended / centrifuged three times with cold methanol
(stored at -20°C) and three times with cold acetone (-20°C).
The protein pellets from 2D Clean Up and phenol
extraction methods were all finally resuspended in
DIGE Label Buffer (7 M urea, 2 M thiourea, 2%
ASB-14 (w/v), 10 mM DTT, 0.5 M EDTA, Complete
EDTA free (Roche), 50 mM Tris-HCl pH 8.5). Proteinconcentration was estimated by using RC/DC Protein
Assay Kit (BioRad Laboratories) and was adjusted between
5 and 10 mg/mL prior CyDye labeling.
2D-DIGE Electrophoresis
All 2D-DIGE experiments were conducted on biological
triplicates (3 samples from 3 different mice for each TG
level group). Each biological replicate was labeled with both
Cy3 and Cy5 (“inversion of labeling”) as a supplementary
experimental duplicate to avoid any fluorescence
artifact, subsequently generating 2×3 = 6 experimental
samples for each condition. For the mitoproteome analysis
(3 conditions: WT, LE, HE), 3×(2×3) = 18 experimental
samples were thereby generated (9 Cy3- and 9 Cy5-labeled)
and had therefore to be dispatched within 9 different 2D
gels. For the other analyses (2 conditions: WT, HE), there
were 2×(2×3) = 12 experimental samples (6 Cy3 and 6
Cy5-labeled) to be distributed within 6 gels. A Cy2-labeled
internal standard (e.g. a pool containing an equal amount
of all biological samples) was also loaded on each 2D gel to
enable subsequent matching and normalization for inter-
gel comparisons, making a total of 18 + 9 = 27 samples for
the mitoproteome analysis and 12 + 6 = 18 samples for the
other analyses. Twenty five μg of each protein extract were
labeled with 0.2 nmole of CyDye (GE Healthcare), for
30 minutes at room temperature. Labeling reactions were
stopped by adding 0.5 nmole lysine. Cy2-, Cy3- and
Cy5-labelled protein were then pooled together prior
to isoelectrofocusing. Pooled samples were reduced by
adding 10 mM DTT and then resuspended in the rehydra-
tion buffer (7 M Urea, 2 M thiourea, 2% ASB-14, and 0.6%
of IPG Buffer (GE Healthcare)) to reach a final volume of
450 μl, and laid on a 24 cm regular strip holder (GE
Healthcare). 3-11 NL IPG Drystrips (GE Healthcare) were
passively rehydrated in the strip holder for 6 h prior iso-
electrofocusing. IEFs were run in the following condition
at 20°C: 50 V for 5 h (step), 500 V for 500 Vhr (Step),
1000 V for 800Vhr (Gradient), 8000 V for 13 500Vhr
(gradient) and 8000 V for 51 000 Vhr (Step) with a max-
imum current setting fixed at 50 μA. After isoelectrofocus-
ing, strips were reduced in equilibration buffer (50%
glycerol (v/v), 2% SDS (w/v), 6 M urea, 50 mM Tris-HCl,
pH 8.8) containing 1% DTT (w/v) for 20 minutes. Then,
strips were alkylated in the same buffer containing 2.5%
iodoacetamide (w/v) for 20 minutes. After equilibration
strips were put on top of a 12.5% acrylamide gel (w/v) for
mitochondrial analysis, and on 10% acrylamide gel for cellu-
lar analysis, in Laemmli SDS electrophoresis buffer (25 mM
Tris, 192 mM Glycine, 1% SDS (w/v)). Electrophoresis was
carried out overnight at 1 W/gel (constant power).
Protein detection, quantitation and statistical analyses
Gels were scanned with the Typhoon 9400 scanner
(GE Healthcare) at the wavelengths corresponding to each
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images were obtained for the mitoproteome analysis (3
conditions: WT, LE, HE) and 18 for the other analyses (2
conditions: WT and HE). Gels images were analyzed with
the DeCyder 7.0 software (GE Healthcare). Briefly, codetec-
tion of the three CyDye-labeled forms of each spot was
performed using the DIA (Differential In-gel Analysis)
module. The DIA module performs the spot detec-
tion, the ratio calculation, and the spot abundance
normalization via the internal standard. Statistical analyses
were carried out in the BVA (Biological Variation Analysis)
module after intergel matching. Protein spots that showed
a statistically significant Student’s t-test (p ≤ 0.05, n = 6) and
ANOVA-1 (p ≤ 0.05, n = 6) for an increase or decrease
ranging up to +1.2 or down to -1.2 in normalized
ratio intensity were accepted as being differentially
expressed between wild-type and HTG mice. In order to
ensure relevant quantitation and avoiding any bias due to the
extraction methods, Student’s t-test applied to matrix
and inner-membrane 2D-DIGE comparisons were
considered as significant when ≤ 0.01. Statistical analyses
for the re-normalization procedure were performed by
using Excel (Microsoft) and JMP 10 (SAS) software.
In gel digest and mass spectrometry
Matched spots presenting a statistical difference between
wild-type and HTG experimental groups were picked
using the Ettan Dalt Spot Picker (GE Healthcare).
Proteins in gel pieces were subsequently in-gel digested
according to Shevchenko et al. [56], with some changes.
Gel pieces were sequentially washed 3 times with 25 mM
NH4HCO3 and 100% acetonitrile (ACN) to remove excess
of detergent and buffer. After the last dehydration in
ACN, pieces of gels were rehydrated for 1 h at 4°C with
2 μL of a 5 μg/mL trypsin proteomic grade solution
(Roche) diluted in 25 mM NH4HCO3 in order to ensure
sufficient trypsin diffusion and to prevent autocatalysis.
Finally, the temperature was raised to 37°C for an overnight
digestion.
Peptides were extracted by adding 5 μL of a 1%
trifluoroacetic acid (TFA) (v/v)/30% ACN (v/v) solution
and vortexed for 30 min. Two μL of the resulting extract
was dropped on a 384-600 MTP Anchorchip MALDI
target plate (Bruker Daltonics) previously spotted with a
30 mg/mL HCCA matrix (Sigma) solution diluted in
acetone. After drop drying, each spot was desalted with
cold 10 mM ammonium phosphate solution. Acquisition
of mass spectra was carried out using MALDI-TOF/TOF
instrumentation (Ultraflex II, Bruker Daltonics) in MS
and LIFT MS/MS modes. Mass spectra were analyzed and
resulting data were formatted for subsequent database
search using the FlexAnalysis software from Bruker
Daltonics. MS and MS/MS data were then used for
protein identification in the UniProt non-redundantprotein database restricted to Mus musculus (taxon
identifier 10090; 43,537 sequences in the reference prote-
ome set) using MASCOT PMF and MS/MS ion algorithms,
respectively, as search engines (www.matrixscience.com)
with the Bio Tools software (Bruker Daltonics) as interface.
For database search, mass error tolerance was fixed at
70 ppm and peptide modifications were assessed as cysteine
carbamidomethylation (fixed modification) and methionine
oxidation (variable modification). Identified proteins were
classified according to their function and sub-cellular or
sub-mitochondrial localization on the basis of data reported
in UniProtKB/Swiss-Prot and in KEGG Pathway.Additional files
Additional file 1: Supplementary figures and tables.
Additional file 2: Mass spectrometry identification and expression
variation of PSOI from mitoproteome comparison. Protein spots of
which the expression level significantly varies in mitochondrial
comparisons of HTG LE or HE mice vs control mice (p ≤ 0.05, ± 1.2),
classified according to their cellular localization and general function.
Protein spots exhibiting biologically significant variation were coloured in
blue, protein spots exhibiting statistically significant variation were marked in
bold characters. Thirty-four spots exhibited biologically significant variation
only in HTG LE vs HTG HE comparison (results not showed) and were
coloured in red. Master Number, position of the protein spot in the master
gel; Ratio LE or HE, ratio between the normalized volume of the protein spot
in control and HTG LE or HE conditions; pI, Isoelectric point; Mw, Molecular
Weight; MIM, Mitochondrial Inner Membrane; MAT, Matrix; MOM,
Mitochondrial Outer Membrane; IMS, Inter-Membrane Space; ER, Endoplasmic
Reticulum; PER, Peroxisome; NUCL, Nucleus; CYTOP, Cytoplasm; CYTOS,
Cytoskeleton; EXT, Extra-cellular; UNKN, Unknown.
Additional file 3: Supplementary methods.
Additional file 4: Outliers excluded from the re-normalization
procedure. Master Number, position of the protein spot in the master
gel; Ratio, ratio between the normalized volume of the protein spot in
control and HTG LE or HE conditions; pI, Isoelectric point; Mw, Molecular
Weight; MIM, Mitochondrial Inner Membrane; MAT, Matrix.
Additional file 5: Calculation of re-normalized protein spots ratio
for matrix and inner membrane proteomes in WT vs LE and HE
comparisons. Results are classified according to proteomes and
comparisons. Spots that presented biological relevant variation after
renormalization procedure are coloured in blue (ratio ≤ 0.83; down-
regulation) or red (ratio ≥ 1.2; up-regulation). Master Number, position of
the protein spot in the master gel; Ratio LE or HE, ratio between the
normalized volume of the protein spot in control and HTG LE or HE
conditions; pI, Isoelectric point; Mw, Molecular Weight.
Additional file 6: Mass spectrometry identification and expression
variation of PSOI from mitochondrial matrix proteome comparison.
Protein spots of which the expression level significantly varies in 2D-DIGE
comparison of experimentally isolated matrix proteome from HTG HE
mice vs control mice (p ≤ 0.01, ± 1.2), classified according to their general
function. Master Number, position of the protein spot in the master gel;
Ratio, ratio between the normalized volume of the protein spot in control
and HTG HE conditions; pI, Isoelectric point; Mw, Molecular Weight.
Additional file 7: Mass spectrometry identification and expression
variation of PSOI from mitochondrial inner membrane proteome
comparison. Protein spot of which the expression level significantly
varies in 2D-DIGE comparison of experimentally isolated mitochondrial
inner-membrane proteome from HTG HE mice vs control mice (p ≤ 0.01,
± 1.2). Master Number, position of the protein spot in the master gel;
Ratio, ratio between the normalized volume of the protein spot in control
and HTG HE conditions; pI, Isoelectric point; Mw, Molecular Weight.
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variation of PSOI from cellular proteome comparison. Protein spots
of which the expression level significantly varies in 2D-DIGE comparison
of cellular proteome from HTG HE mice vs control mice (p ≤ 0.05, ± 1.2),
classified according to their general function. Master Number, position of
the protein spot in the master gel; Ratio, ratio between the normalized
volume of the protein spot in control and HTG HE conditions; pI, Isoelectric
point; Mw, Molecular Weight.
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